Data / Drug companies / Tadalafil
Tadalafil: 54 companies and 254 products in the FDA NDC directory
Tadalafil is listed in the FDA National Drug Code Directory by 54 companies, with 254 products in commercial distribution. 248 of the products (97.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet; tablet, coated, and the newest product started marketing on August 3, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 54
- Products
- 254
- Generic (ANDA) products
- 248 (97.6%)
- Application numbers
- 34
- Routes
- Oral
- Brand names
- Cialis, Tadliq, Adcirca, Alyq
- openFDA record search
- api.fda.gov
Companies that list tadalafil
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| NuCare Pharmaceuticals,Inc. | 18 | tablet; tablet, film coated | Generic drugs (ANDA) | January 18, 2022 |
| Asclemed USA, Inc. | 15 | tablet, film coated; tablet | Generic drugs (ANDA) | February 19, 2020 |
| Bryant Ranch Prepack | 13 | tablet, film coated; tablet | Generic drugs (ANDA) | January 18, 2022 |
| A-S Medication Solutions | 11 | tablet, film coated; tablet | Generic drugs (ANDA) | February 15, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | 9 | tablet; tablet, film coated | Generic drugs (ANDA) | November 27, 2024 |
| Solco Healthcare US, LLC | 9 | tablet | Generic drugs (ANDA) | November 27, 2024 |
| Proficient Rx LP | 8 | tablet, film coated; tablet | Generic drugs (ANDA) | April 3, 2020 |
| PD-Rx Pharmaceuticals, Inc. | 7 | tablet, film coated; tablet | Generic drugs (ANDA) | April 1, 2023 |
| Preferred Pharmaceuticals Inc. | 7 | tablet; tablet, film coated | Generic drugs (ANDA) | February 27, 2026 |
| Remedyrepack Inc. | 7 | tablet; tablet, film coated | Generic drugs (ANDA) | April 22, 2026 |
| Ajanta Pharma USA Inc. | 5 | tablet | Generic drugs (ANDA) | July 4, 2022 |
| Aurobindo Pharma Limited | 5 | tablet, film coated; tablet | Generic drugs (ANDA) | March 26, 2019 |
| Camber Pharmaceuticals, Inc. | 5 | tablet, film coated; tablet | Generic drugs (ANDA) | March 26, 2019 |
| Dr. Reddy's Laboratories Inc. | 5 | tablet, film coated | Generic drugs (ANDA) | March 26, 2019 |
| Macleods Pharmaceuticals Limited | 5 | tablet, film coated | Generic drugs (ANDA) | October 17, 2019 |
| Proficient Rx LP | 5 | tablet, film coated | Generic drugs (ANDA) | November 2, 2020 |
| Torrent Pharmaceuticals Limited | 5 | tablet | Generic drugs (ANDA) | March 26, 2019 |
| Accord Healthcare Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | April 3, 2020 |
| Alembic Pharmaceuticals Inc. | 4 | tablet, coated | Generic drugs (ANDA) | March 26, 2019 |
| Alembic Pharmaceuticals Limited | 4 | tablet, coated | Generic drugs (ANDA) | March 26, 2019 |
| Amneal Pharmaceuticals NY LLC | 4 | tablet, film coated | Generic drugs (ANDA) | March 27, 2019 |
| Amneal Pharmaceuticals NY LLC | 4 | tablet, film coated | Generic drugs (ANDA) | March 27, 2019 |
| AvKARE | 4 | tablet, film coated | Generic drugs (ANDA) | January 21, 2021 |
| Bostal LLC | 4 | tablet, film coated | Generic drugs (ANDA) | November 29, 2019 |
| Burel Pharmaceuticals, LLC | 4 | tablet, film coated | Generic drugs (ANDA) | April 1, 2023 |
| Fourrts (india) Laboratories Private Limited | 4 | tablet, film coated | Generic drugs (ANDA) | August 21, 2024 |
| Hec Pharm USA Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | March 27, 2019 |
| Nivagen Pharmaceuticals, Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | November 2, 2020 |
| NorthStar Rx LLC | 4 | tablet, film coated | Generic drugs (ANDA) | February 19, 2020 |
| NorthStar RxLLC | 4 | tablet, film coated | Generic drugs (ANDA) | August 3, 2026 |
| Qilu Pharmaceutical Co., Ltd. | 4 | tablet, film coated | Generic drugs (ANDA) | November 17, 2021 |
| Sun Pharmaceutical Industries, Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | March 26, 2019 |
| Umedica Laboratories USA Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | February 15, 2026 |
| Unichem Pharmaceuticals (USA), Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | March 26, 2019 |
| Upsher-Smith Laboratories, LLC | 4 | tablet, film coated | Generic drugs (ANDA) | April 7, 2024 |
| VKT Pharma Private Limited | 4 | tablet, film coated | Generic drugs (ANDA) | November 4, 2021 |
| XLCare Pharmaceuticals, Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | December 10, 2024 |
| Zydus Lifesciences Limited | 4 | tablet, film coated | Generic drugs (ANDA) | March 27, 2019 |
| Zydus Pharmaceuticals USA Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | March 27, 2019 |
| Ani Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | March 6, 2023 |
| Bryant Ranch Prepack | 3 | tablet, film coated; tablet | Generic drugs (ANDA) | March 27, 2019 |
| Eli Lilly and Company | 3 | tablet, film coated | New drug applications (NDA) | November 26, 2003 |
| Northwind Health Company, LLC | 3 | tablet, film coated | Generic drugs (ANDA) | September 27, 2022 |
| Quallent Pharmaceuticals Health LLC | 3 | tablet | Generic drugs (ANDA) | July 19, 2023 |
| Teva Pharmaceuticals, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | February 20, 2024 |
| Advanced Rx of Tennessee, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | October 15, 2024 |
| AvKARE | 1 | tablet | Generic drugs (ANDA) | August 11, 2025 |
| CMP Pharma, Inc. | 1 | suspension | New drug applications (NDA) | August 30, 2022 |
| Cipla USA Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | February 5, 2019 |
| Direct_Rx | 1 | tablet | Generic drugs (ANDA) | November 12, 2020 |
| Lupin Pharmaceuticals, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | February 11, 2019 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | November 16, 2023 |
| Redpharm Drug | 1 | tablet, film coated | Generic drugs (ANDA) | March 26, 2019 |
| United Therapeutics Corporation | 1 | tablet | New drug applications (NDA) | May 22, 2009 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 169 | 66.5% |
| Tablet | 76 | 29.9% |
| Tablet, coated | 8 | 3.1% |
| Suspension | 1 | 0.4% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 248 | 97.6% |
| New drug applications (NDA) | 5 | 2% |
| Other unapproved drugs | 1 | 0.4% |
Pharmacologic classes
| Class | Products |
|---|---|
| Phosphodiesterase 5 Inhibitor | 254 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.